Fetal and neonatal liver disease.
The pathology of fetal and neonatal liver disease is reviewed and particular emphasis is laid on discriminating between diseases of known aetiology or of genetic importance and idiopathic disorders. These are discussed in relation to the particular metabolic differences between the fetal an neonatal liver and the adult liver. Common disorders such as rhesus isoimmunization are only touched on in respect of their effects on the metabolic function of the liver. The importance of iatrogenic disease in this age group is stressed.
D001647:Bile Acids and Salts / Q000378:metabolism; D001652:Bile Ducts / Q000002:abnormalities; D002779:Cholestasis / Q000473:pathology; D005260:Female; D005315:Fetal Diseases / Q000473:pathology*; D005333:Fetus / Q000378:metabolism; D006505:Hepatitis / Q000473:pathology; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000473:pathology*; D007567:Jaundice, Neonatal / Q000209:etiology / Q000473:pathology; D008099:Liver / Q000378:metabolism / Q000473:pathology*; D008102:Liver Circulation; D008103:Liver Cirrhosis / Q000473:pathology; D008107:Liver Diseases / Q000196:embryology / Q000473:pathology*; D008113:Liver Neoplasms / Q000473:pathology; D008661:Metabolism, Inborn Errors / Q000473:pathology; D011247:Pregnancy
D001647:Bile Acids and Salts